目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 INCLUSIONS AND EXCLUSIONS
1.3.2 MARKETS COVERED
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 PRIMARY DATA
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
2.1.2.2 INSIGHTS FROM PRIMARY EXPERTS
2.3 MARET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT
2.8 IMPACT OF ECONOMIC RECESSION

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.2 COMPLIMENTARY TECHNOLOGIES
5.3.3 ADJACENT TECHNOLOGIES
5.4 INDUSTRY TRENDS
5.5 DISEASE TRENDS
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 PORTER'S FIVE FORCE ANALYSIS
5.9 TARIFF AND REGULATORY LANDSCAPE
5.9.1 REGULATORY ANALYSIS
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION
5.10 PATENT ANALYSIS
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.11.2 AVERAGE SELLING PRICE TREND, BY REGION
5.12 KEY CONFERENCES & EVENTS DURING 2023-2024
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS & BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 TRADE ANALYSIS
5.15 ECOSYSTEM/MARKET MAP
5.16 ADJACENT MARKET ANALYSIS
5.17 UNMET NEEDS ANALYSIS/END-USER EXPECTATIONS
5.18 AI INTEGRATION
5.19 CASE STUDY ANALYSIS

6 VETERINARY DIAGNOSTIC MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
6.1 INTRODCUTION
6.2 CONSUMABLES
6.3 INSTRUMENTS

7 VETERINARY DIAGNOSTIC MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
7.1 INTRODUCTION
7.2 CLINICAL BIOCHEMISTRY
7.2.1 CLINICAL CHEMISTRY ANALYSIS
7.2.1.1 CLINICAL CHEMISTRY REAGENT CLIPS & AND CARTRIDGES
7.2.1.2 CLINICAL CHEMISTRY ANALYZERS
7.2.2 GLUCOSE MONITORING
7.2.2.1 BLOOD GLUCOSE STRIPS
7.2.2.2 GLUCOSE MONITORS
7.2.2.3 URINE GLUCOSE STRIPS
7.2.3 BLOOD GAS & ELECTROLYTE ANALYSIS
7.2.3.1 BLOOD GAS AND ELECTROLYTE REAGENT CLIPS AND CARTRIDGES
7.2.3.2 BLOOD GAS & ELECTROLYTE ANALYZERS
7.3 MOLECULAR DIAGNOSTICS
7.3.1 POLYMERASE CHAIN REACTION (PCR) TESTS
7.3.2 NUCLEIC ACID SEQUENCING
7.3.3 MICROARRAYS
7.3.4 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
7.4 HEMATOLOGY
7.4.1 HEMATOLOGY CARTRIDGES
7.4.2 HEMATOLOGY ANALYZER
7.5 URINALYSIS
7.5.1 URINALYSIS CLIPS & CARTRIDGES/PANELS
7.5.2 URINE ANALYZERS
7.5.3 URINE TEST STRIPS
7.7 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES

8 VETERINARY DIAGNOSTIC MARKET, BY ANIMAL TYPE, 2021-2029 (USD MILLION)
8.1 INTRODCUTION
8.2 COMPANION ANIMALS
8.2.1 DOGS
8.2.2 CATS
8.2.3 HORSES
8.2.4 OTHER COMPANION ANIMALS
8.3 LIVESTOCK
8.3.1 CATTLE
8.3.2 PIGS
8.3.3 POULTRY
8.3.4 OTHER LIVESTOCK

9 VETERINARY DIAGNOSTIC MARKET, BY APPLICATION, 2021-2029 (USD MILLION)
9.1 INTRODCUTION
9.2 INFECTIOUS DISEASE
9.2.1 BACTERIAL INFECTION
9.2.2 VIRAL INFECTION
9.2.3 PARASITIC INFECTION
9.2.4 OTHER INFECTION
9.3 ENDOCRINOLOGY
9.4 ONCOLOGY
9.5 CARDIOLOGY
9.6 NEUROLOGY
9.7 OTHER APPLICATIONS

10 VETERINARY DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2029 (USD MILLION)
10.1 INTRODCUTION
10.2 DIRECT SALES
10.3 WHOLESALE AND DISTRIBUTORS
10.4 ONLINE SALES PLATFORMS

11 VETERINARY DIAGNOSTIC MARKET, BY END-USER, 2021-2029 (USD MILLION)
11.1 INTRODUCTION
11.2 VETERINARY REFERENCE LABORATORIES
11.3 VETERINARY HOSPITALS & CLINICS
11.4 POINT-OF-CARE/ IN-HOUSE TESTING
11.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES

12 VETERINARY DIAGNOSTIC MARKET, BY REGION, 2021-2029 (USD MILLION)
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 IMPACT OF ECONOMIC RECESSION
12.2.2 US
12.2.3 CANADA
12.3 EUROPE
12.3.1 IMPACT OF ECONOMIC RECESSION
12.3.2 GERMANY
12.3.3 FRANCE
12.3.4 UK
12.3.5 ITALY
12.3.6 SPAIN
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 IMPACT OF ECONOMIC RECESSION
12.4.2 JAPAN
12.4.3 CHINA
12.4.4 INDIA
12.4.5 AUSTRALIA
12.4.6 SOUTH KOREA
12.4.7 ROAPAC
12.5 LATIN AMERICA
12.5.1 IMPACT OF ECONOMIC RECESSION
12.5.2 BRAZIL
12.5.3 MEXICO
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 IMPACT OF ECONOMIC RECESSION

13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
13.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
13.4 COMPANY EVALUATION MATRIX
13.4.1 STARS
13.4.2 EMERGING LEADERS
13.4.3 PERVASIVE PLAYERS
13.4.4 PARTICIPANTS
13.4.5 COMPANY FOOTPRINT
13.5 START-UP/SME EVALUATION MATRIX
13.5.1 PROGRESSIVE COMPANIES
13.5.2 RESPONSIVE COMPANIES
13.5.3 DYNAMIC COMPANIES
13.5.4 STARTING BLOCKS
13.5.5 COMPETITIVE BENCHMARKING
13.6 MARKET SHARE ANALYSIS
13.7 COMPETITIVE SITUATION AND TRENDS
13.7.1 PRODUCT LAUNCHES & APPROVALS
13.7.2 DEALS
13.7.3 OTHER DEVELOPMENTS

14 COMPANY PROFILE
14.1 KEY PLAYERS
14.1.1 IDEXX LABORATORIES INC.
14.1.2 ZOETIS INC.
14.1.3 THERMO FISHER SCIENTIFIC INC.
14.1.4 MARS, INCORPORATED (PREVIOUSLY KNOWN AS HESKA CORPORATION)
14.1.5 BIOMERIEUX SA
14.1.6 NEOGEN CORPORATION
14.1.7 BIO-RAD LABORATORIES INC.
14.1.8 VIRBAC
14.1.9 FUJIFILM HOLDINGS CORPORATION
14.1.10 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO LTD.
14.1.11 INDICAL BIOSCIENCE GMBH
14.1.12 BIONOTE INC.
14.1.13 BIOGAL GALED LABS
14.1.14 AGROLABO S.P.A
14.1.15 INNOVATIVE DIAGNOSTICS
14.2 OTHER PLAYERS
14.2.1 RANDOX LABORATORIES
14.2.2 BIOCHECK
14.2.3 FASSISSI GMBH
14.2.4 ALVEDIA
14.2.5 SKYER INC.
14.2.6 SHENZHEN BIOEASY BIOTECHNOLOGY CO LTD
14.2.7 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
14.2.8 PRECISION BIOSENSOR INC.
14.2.9 ANTECH DIAGNOSTICS
14.2.10 GOLD STANDARD DIAGNOSTICS

15 APPENDIX
15.1 INSIGHTS OF INDUSTRY EXPERTS
15.2 DISCUSSION GUIDE
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS